These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 18849357

  • 1. CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.
    Parlevliet ET, Schröder-van der Elst JP, Corssmit EP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H.
    J Pharmacol Exp Ther; 2009 Jan; 328(1):240-8. PubMed ID: 18849357
    [Abstract] [Full Text] [Related]

  • 2. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
    Parlevliet ET, de Leeuw van Weenen JE, Romijn JA, Pijl H.
    Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
    [Abstract] [Full Text] [Related]

  • 3. Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.
    Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP.
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E142-7. PubMed ID: 17971509
    [Abstract] [Full Text] [Related]

  • 4. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
    Li L, Yang G, Li Q, Tang Y, Li K.
    Ann Nutr Metab; 2006 Jan; 50(6):499-505. PubMed ID: 17191023
    [Abstract] [Full Text] [Related]

  • 5. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E, Wood JA, Stanojevic V, Habener JF.
    Regul Pept; 2011 Aug 08; 169(1-3):43-8. PubMed ID: 21549160
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK, van de Werve G, Giacca A.
    Am J Physiol Endocrinol Metab; 2003 Feb 08; 284(2):E281-90. PubMed ID: 12531742
    [Abstract] [Full Text] [Related]

  • 9. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA, Ferre T, Ayala JE, King EM, Holt RM, Ayala JE.
    Am J Physiol Endocrinol Metab; 2012 Feb 01; 302(3):E334-43. PubMed ID: 22094469
    [Abstract] [Full Text] [Related]

  • 10. Hepatic glucose production is more sensitive to insulin-mediated inhibition than hepatic VLDL-triglyceride production.
    den Boer MA, Voshol PJ, Kuipers F, Romijn JA, Havekes LM.
    Am J Physiol Endocrinol Metab; 2006 Dec 01; 291(6):E1360-4. PubMed ID: 16849628
    [Abstract] [Full Text] [Related]

  • 11. Lipoproteins abnormalities in obese insulin-resistant dogs.
    Bailhache E, Nguyen P, Krempf M, Siliart B, Magot T, Ouguerram K.
    Metabolism; 2003 May 01; 52(5):559-64. PubMed ID: 12759884
    [Abstract] [Full Text] [Related]

  • 12. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec 01; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 13. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M.
    Am J Physiol Endocrinol Metab; 2002 Jul 01; 283(1):E12-9. PubMed ID: 12067837
    [Abstract] [Full Text] [Related]

  • 14. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B, Mika A, Nguyen P, Wilcox D, Ohman L, von Geldern TW, Opgenorth T, Jacobson P.
    Metabolism; 2007 Mar 01; 56(3):380-7. PubMed ID: 17292727
    [Abstract] [Full Text] [Related]

  • 15. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
    van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP, Pijl H.
    Am J Physiol Endocrinol Metab; 2007 Jan 01; 292(1):E238-45. PubMed ID: 16940471
    [Abstract] [Full Text] [Related]

  • 16. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice.
    Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH.
    Diabetes; 2007 Apr 01; 56(4):1025-33. PubMed ID: 17229936
    [Abstract] [Full Text] [Related]

  • 17. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.
    Obesity (Silver Spring); 2010 Apr 01; 18(4):780-7. PubMed ID: 19798065
    [Abstract] [Full Text] [Related]

  • 18. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
    Shafrir E, Ziv E, Saha AK, Ruderman NB.
    Diabetes Metab Res Rev; 2002 Apr 01; 18(3):217-23. PubMed ID: 12112940
    [Abstract] [Full Text] [Related]

  • 19. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.
    van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM, Pijl H.
    Diabetes; 2004 Aug 01; 53(8):1949-52. PubMed ID: 15277371
    [Abstract] [Full Text] [Related]

  • 20. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
    Wu H, Sui C, Xu H, Xia F, Zhai H, Zhang H, Weng P, Han B, Du S, Lu Y.
    J Diabetes Res; 2014 Aug 01; 2014():524517. PubMed ID: 25580440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.